|
Showing the most relevant articles for your search:NASDAQ:ALQA 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 | 2019/11/09 | 06 : 21 | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/10/12 | 04 : 09 | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/10/02 | 21 : 31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/08/22 | 19 : 04 | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/08/14 | 20 : 38 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/08/14 | 20 : 33 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/08/14 | 05 : 42 | Edgar (US Regulatory) | Information Statement - All Other (definitive) (def 14c) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/08/03 | 05 : 31 | Edgar (US Regulatory) | Proxy Statement - Other Information (preliminary) (pre 14c) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/08/02 | 06 : 07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/08/01 | 22 : 53 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/07/25 | 19 : 05 | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/07/22 | 19 : 31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/06/26 | 21 : 31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/06/18 | 06 : 28 | Edgar (US Regulatory) | Securities Registration Statement (s-1) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/06/18 | 06 : 23 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/06/13 | 01 : 46 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/06/11 | 05 : 24 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/06/01 | 05 : 58 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/05/15 | 05 : 37 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/05/14 | 06 : 12 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/05/14 | 05 : 59 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/05/14 | 05 : 47 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/05/10 | 19 : 00 | GlobeNewswire Inc. | Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/05/10 | 06 : 29 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/05/07 | 00 : 05 | GlobeNewswire Inc. | Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/04/25 | 06 : 30 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/04/24 | 03 : 03 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/04/22 | 23 : 06 | GlobeNewswire Inc. | Alliqua BioMedical CEO Provides Update to Shareholders | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/04/13 | 06 : 01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
2019/04/12 | 05 : 49 | GlobeNewswire Inc. | Alliqua BioMedical Declares Contingent Special Dividend of $1.05 per Share and Announces Record Date for the Contingent Speci... | NASDAQ:ALQA | Alliqua Biomedical, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:ALQA |
|